21 Publications
2012
Tissue-specific alterations of PRL-1 and PRL-2 expression in cancer.
Dumaual, Carmen MDumaual, Carmen MSandusky, George ESandusky, George ESoo, Han WSoo, Han WengWerner, Sean RWerner, Sean RCrowell, Pamela LCrowell, Pamela LRandall, Stephen K and Randall, Stephen
American journal of translational research, vol. 4, (no. 1), pp. 83-101, 2012. | Journal Article
2007
Cell cycle arrest by the isoprenoids perillyl alcohol, geraniol, and farnesol is mediated by p21(Cip1) and p27(Kip1) in human pancreatic adenocarcinoma cells.
Wiseman, Dean AWerner, Sean R and Crowell, Pamela L
The Journal of pharmacology and experimental therapeutics, vol. 320, (no. 3), pp. 1163-70, 2007/Mar. | Journal Article
2006
Cellular localization of PRL-1 and PRL-2 gene expression in normal adult human tissues.
Dumaual, Carmen MSandusky, George ECrowell, Pamela L and Randall, Stephen
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society, vol. 54, (no. 12), pp. 1401-12, 2006/Dec. | Journal Article
2003
Enhanced cell cycle progression and down regulation of p21(Cip1/Waf1) by PRL tyrosine phosphatases.
Werner, Sean RLee, Paul ADeCamp, Matthew WCrowell, Dring NRandall, Stephen and Crowell, Pamela L
Cancer letters, vol. 202, (no. 2), pp. 201-11, 2003/Dec/30. | Journal Article
 
Enhanced cell cycle progression and down regulation of p21 super(Cip1/Waf1) by PRL tyrosine phosphatases
Werner, S. RLee, PADeCamp, MWCrowell, DNRandall, Stephen K and Crowell, Pamela L
Cancer Letters, vol. 202, (no. 2), pp. 201-211, 2003. | Journal Article
2002
Effects of the isoprenoids perillyl alcohol and farnesol on apoptosis biomarkers in pancreatic cancer chemoprevention.
Burke, Yvette DAyoubi, A SWerner, Sean RMcFarland, Bryan CHeilman, Douglas KRuggeri, Bruce A and Crowell, Pamela L
Anticancer research, vol. 22, (no. 6A), pp. 3127-34, 2002 Nov-Dec. | Journal Article
 
Effects of the Isoprenoids Perillyl Alcohol and Farnesol on Apoptosis Biomarkers in Pancreatic Cancer Chemoprevention.
Burke YDAyoubi ASWerner SRMcFarland BCHeilman DKRuggeri BA and Crowell, Pamela L
(pp. 3127-34). Nov-Dec 2002
2001
Cell cycle effects of nonsteroidal anti-inflammatory drugs and enhanced growth inhibition in combination with gemcitabine in pancreatic carcinoma cells.
Yip Schneider, Michele TYip-Schneider, MicheleSweeney, C JSweeney, ChristopherJung, S HJung, Sin-HoCrowell, PamelaCrowell, Pamela LMarshall, M S and Marshall, Mark
The Journal of pharmacology and experimental therapeutics, vol. 298, (no. 3), pp. 976-85, 2001/Sep. | Journal Article
2000
Cyclooxygenase-2 expression in human pancreatic adenocarcinomas.
Yip Schneider, Michele TBarnard, D SBillings, S DCheng, LiangHeilman, D KLin, AMarshall, S JCrowell, Pamela LMarshall, M S and Sweeney, Christopher J
Carcinogenesis, vol. 21, (no. 2), pp. 139-46, 2000/Feb. | Journal Article
1999
Prevention and therapy of cancer by dietary monoterpenes
Crowell, Pamela L
The Journal of Nutrition, vol. 129, (no. 3), pp. 775S-778S, Mar 1999. | Journal Article
1997
Inhibition of pancreatic cancer growth by the dietary isoprenoids farnesol and geraniol.
Burke, Y.D.Stark, M.J.Roach, S.L.Sen, Stephanie E and Crowell, Pamela L
Lipids., vol. 32, (no. 2), pp. 152-156, 1997. | Journal Article
 
Inhibition of pancreatic cancer growth by the dietary isoprenoids farnesol and geraniol.
Burke, Y DStark, M JRoach, S LSen, Stephanie E and Crowell, Pamela L
Lipids, vol. 32, (no. 2), pp. 151-6, 1997/Feb. | Journal Article
 
Monoterpenes in breast cancer chemoprevention.
Crowell, Pamela L
Breast Cancer Research and Treatment, vol. 46, (no. 2-3), pp. 191-7, 1997 Nov-Dec. | Journal Article
1995
Chemotherapy of pancreatic cancer with the monoterpene perillyl alcohol.
Stark, M JBurke, Y DMcKinzie, J HAyoubi, A S and Crowell, Pamela L
Cancer letters, vol. 96, (no. 1), pp. 15-21, 1995/Sep/4. | Journal Article
1994
Chemoprevention and therapy of cancer by d-limonene.
Crowell, Pamela L and Gould, Michael N
Critical Reviews in Oncogenesis, vol. 5, (no. 1), pp. 1-22, 1994. | Journal Article
 
Human metabolism of the experimental cancer therapeutic agent d-limonene.
Crowell, Pamela LElson, C EBailey, Howard HElegbede, AHaag, J D and Gould, M N
Cancer Chemotherapy and Pharmacology, vol. 35, (no. 1), pp. 31-7, 1994. | Journal Article
 
Structure-activity relationships among monoterpene inhibitors of protein isoprenylation and cell proliferation.
Crowell, Pamela LRen, ZLin, SVedejs, E and Gould, Michael N
Biochemical pharmacology, vol. 47, (no. 8), pp. 1405-15, 1994/Apr/20. | Journal Article
1992
Chemoprevention of mammary carcinogenesis by hydroxylated derivatives of d-limonene.
Crowell, Pamela LKennan, W SHaag, J DAhmad, SVedejs, E and Gould, M N
Carcinogenesis, vol. 13, (no. 7), pp. 1261-4, 1992/Jul. | Journal Article
 
Identification of metabolites of the antitumor agent d-limonene capable of inhibiting protein isoprenylation and cell growth.
Crowell, Pamela LLin, SVedejs, E and Gould, M N
Cancer Chemotherapy and Pharmacology, vol. 31, (no. 3), pp. 205-12, 1992. | Journal Article
1991
Selective inhibition of isoprenylation of 21-26-kDa proteins by the anticarcinogen d-limonene and its metabolites.
Crowell, Pamela LChang, RRRen, Z.Elson, Charles E and Gould, Michael N
Journal of biological chemistry., vol. 266, (no. 26), pp. 17679-685, 1991. | Journal Article
1988
Regulation of rat liver and muscle branched-chain alpha-keto dehydrogenase by diet and hormones (Dissertation)
Crowell, Pamela L (1988).